News
Opinion
Culture & Lifestyle
Community
Business & Tech
Judaism
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Times of Israel Partner
subscribe
Open search field
Open menu button
Search the site
Search query
Clear search input
search
Subscribe to our newsletter
Today’s top stories
– trusted, exclusive,
straight to your inbox.
Subscribe
Email address
Subscribe
The email is either missing or invalid
Search the site
Search query
Clear search input
search
Close menu
News
Opinion
Culture & Lifestyle
Community
Business & Tech
Judaism
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Times of Israel Partner
Donate
Competitions
Job board
Spotlight
E-editions
Jewish News
Magazines
About Us
About Us
Contact Us
Advertise with Us
Where to Find Us
Terms and Conditions
Privacy Policy
Follow us
Facebook
Instagram
Tiktok
Twitter
Youtube
Linkedin
Bluesky
Prefer Jewish News on Google
Subscribe to our newsletter
Today’s top stories
– trusted, exclusive,
straight to your inbox.
Subscribe
Email address
Subscribe
The email is either missing or invalid
© 2026 JewishNews, All Rights Reserved.
Concept, design & development by
Powered by
Salamandra
big pharma
August 18, 2026, 12:23 pm
The Israeli-founded AI company decoding the human immune system
Dr Noam Solomon's Immunai has raised nearly $270m and works with the world's top 20 pharmaceutical companies, including AstraZeneca, Pfizer and Teva
By
Candice Krieger
Load More
Prefer Jewish News on Google
